Evidence map›Paper›PMID 41913226›Full record

ArticleOrphanet journal of rare diseases2026

SGK3 promoter deletion in late-onset hypophosphatemic rickets, a possible genetic cause of the disease.

Ahmet Uçar, Najla Albader, Amal Qattan, Huda A BinEssa, Ebru Mısırlı Özdemir, Mustafa Özdemir, Minjing Zou, Ali S Alzahrani, Yufei Shi

Abstract readCase Reports
In one paragraph

Article in Orphanet journal of rare diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ahmet UçarDepartment of Pediatric Endocrinology & Diabetes, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Najla AlbaderInnovation and Research, King Faisal Specialist Hospital & Research Centre, P.O. Box 3354, Riyadh, 11211, Saudi Arabia.
Amal QattanInnovation and Research, King Faisal Specialist Hospital & Research Centre, P.O. Box 3354, Riyadh, 11211, Saudi Arabia.
Huda A BinEssaInnovation and Research, King Faisal Specialist Hospital & Research Centre, P.O. Box 3354, Riyadh, 11211, Saudi Arabia.
Ebru Mısırlı ÖzdemirDepartment of Pediatric Endocrinology & Diabetes, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Mustafa ÖzdemirDepartment of Pediatric Endocrinology & Diabetes, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Minjing ZouInnovation and Research, King Faisal Specialist Hospital & Research Centre, P.O. Box 3354, Riyadh, 11211, Saudi Arabia.
Ali S AlzahraniMedicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Yufei ShiInnovation and Research, King Faisal Specialist Hospital & Research Centre, P.O. Box 3354, Riyadh, 11211, Saudi Arabia. yufei@kfshrc.edu.sa.ORCID http://orcid.org/0000-0002-6999-0191

Funding

King Abdulaziz City for Science and Technology 13-MED1765-20
6 · The paper itself

Abstract

backgroundHypophosphataemic rickets (HR) is a group of rare hereditary renal phosphate wasting disorders caused by mutations in the PHEX, FGF23, DMP1, ENPP1, CLCN5, SGK3, SLC9A3R1, SLC34A1 or SLC34A3.

objectiveTo identify the genetic defects in a patient with late-onset hypophosphatemia. SUBJECTS: A 15-year old boy with hypophosphatemic rickets, his unaffected parents and 7 siblings.

designPatients and their family members were initially analyzed for PHEX and FGF23 mutations by PCR-sequencing analysis. Exome and whole-genome sequencing were subsequently performed to identify causative genetic defects.

resultsThe patient was normal until the age of 11 years old. He presented with severe rickets, hypophosphatemia with increased renal phosphate wasting, normal serum calcium, 1,25(OH)2D and parathyroid hormone (PTH), and mild elevation of serum FGF23. No mutation was detected in the genes known to cause HR such as PHEX, FGF23, DMP1, ENPP1, CLCN5, SGK3, FAM20C, SLC9A3R1, SLC34A1 or SLC34A3 by exome sequencing. A heterozygous variant c.448 C>T (p.Arg150Cys) in the PTH1R gene was found in the patient, his unaffected father and 5 siblings. The same heterozygous variant was previously reported in human enchondromatosis and caused enchondroma-like lesions in transgenic mice. A large heterozygous deletion of more than 7 Kb in the SGK3 distal promoter was identified in the patient by whole genome sequencing.

conclusionsSGK3 distal promoter deletion is likely the candidate gene causing the disease. PTH1R Arg150Cys variant may contribute to the disease phenotype. SGK3 promoter deletion should be considered in patients with late-onset genetic hypophosphatemic rickets.

Indexed as

Familial Hypophosphatemic RicketsPromoter Regions, GeneticProtein Serine-Threonine KinasesRickets, HypophosphatemicAdolescentFibroblast Growth Factor-23Fibroblast Growth FactorsHumansMaleMutationSerum-Glucocorticoid Regulated KinasesFGF23 protein, humanFgf23 protein, mouseFibroblast Growth Factor-23Fibroblast Growth FactorsProtein Serine-Threonine KinasesSerum-Glucocorticoid Regulated KinasesSGK3 protein, humanHypophosphataemiaPromoterPTH1RRicketsSGK3

Identifiers

PMID41913226
PMCPMC13528025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.